Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Karolinska University Hospital
Sponsor

Karolinska University Hospital

Sweden Eugeniavagen 3, 171 64 Solna, Sweden

About the sponsor

Karolinska University Hospital supports clinical research across a broad range of cancer types, with particular activity in breast cancer, lung cancer, melanoma, gastrointestinal cancers, and gynaecological malignancies. Its portfolio also includes leukaemia, lymphoma, myelodysplastic syndrome, and neuroblastoma.

  • HER2-positive and HER2-low breast cancer
  • Acute myeloid leukaemia and acute lymphoblastic leukaemia
  • Follicular lymphoma and other non-Hodgkin lymphoma subtypes
  • Esophageal, gastric, pancreatic, and colorectal cancer
  • Advanced solid tumours and metastatic melanoma

Research activity also extends to molecular imaging and biomarker-driven assessment in oncology, including work focused on tumour expression profiling and treatment selection.

About Specializations

Karolinska University Hospital runs clinical trials in conditions such as Atrial fibrillation, Rheumatoid arthritis, Breast cancer, Acute myeloid leukaemia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

53 clinical trials

Acute myeloid leukaemia

Recruiting

A study of hydroxyurea added to standard drug combination to assess safety and effectiveness in adults with relapsed or refractory acute myeloid leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Karolinska University Hospital

Neoplasm malignant

Recruiting

A Study of Sodium Selenite Followed by Chemotherapy in Patients with Advanced Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium selenite pentahydrate
  • Sponsor:Karolinska University Hospital

Metastatic gastric cancer

Recruiting

Study of intraperitoneal paclitaxel combined with systemic therapy versus systemic therapy alone for patients with gastric cancer and peritoneal metastases

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Karolinska University Hospital

Hypertension

Recruiting

Evaluating Citrulline, Folic Acid, Vericiguat, and Tadalafil Combination for Patients with Treatment-Resistant High Blood Pressure

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid
  • Sponsor:Karolinska University Hospital

Prostate cancer

Recruiting

Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Karolinska University Hospital

Cardiac arrest

Recruiting

Study on Levosimendan for Improving Survival in Patients with Out-of-Hospital Cardiac Arrest During CPR

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Levosimendan
  • Sponsor:Karolinska University Hospital

Oral neoplasm

Recruiting

Study of Nivolumab for Patients with Oral Cancer to Reduce Tumor Size Before Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Karolinska University Hospital

Malignant melanoma stage III

Recruiting

Study Comparing Ipilimumab and Nivolumab to Nivolumab Alone for Patients with Resectable Stage III Melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Karolinska University Hospital

Breast cancer female

Recruiting

Study on Imaging and Treatment Prediction for Metastatic Breast Cancer Using Gallium (68Ga) Tezatabep Matraxetan and Trastuzumab Deruxtecan

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gallium (68GA) tezatabep matraxetan
  • Sponsor:Karolinska University Hospital

Follicular lymphoma

Recruiting

Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital

Type 1 diabetes mellitus+1

Recruiting

Study on Deferoxamine to Improve Hypoxia Response in Type 1 Diabetes Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Deferoxamine Mesilate
  • Sponsor:Karolinska University Hospital

Atrial fibrillation

Recruiting

Study on Preventing Atrial Fibrillation Recurrence After Cardioversion Using Dapagliflozin in Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Karolinska University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.